About Uncharacterized protein C3orf38
Uncharacterized protein C3orf38 (C3orf38) is a protein
from Homo sapiens identified by UniProt accession
Q5JPI3, 329 residues long.
MolForge cross-references it against 0 known binders and
191 disease associations.
Target properties
| Protein name | Uncharacterized protein C3orf38 |
|---|
| UniProt accession | Q5JPI3 |
|---|
| Gene | C3orf38 |
|---|
| Organism | Homo sapiens |
|---|
| Length | 329 residues |
|---|
| Molecular weight | — |
|---|
| EC numbers | — |
|---|
| Target class | UNCLASSIFIED |
|---|
| Subcellular location | — |
|---|
| Keywords | — |
|---|
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|
| Druggability score | — |
|---|
| Pocket score | — |
|---|
| Max clinical phase | — |
|---|
Disease associations (191)
Diseases linked to this target (Open Targets).
- platelet count · score 0.30
- age at first sexual intercourse measurement · score 0.29
- mean corpuscular hemoglobin concentration · score 0.28
- mean corpuscular volume · score 0.27
- body mass index · score 0.27
- erythrocyte count · score 0.25
- mean corpuscular hemoglobin · score 0.25
- diet measurement · score 0.25
- IGF-1 measurement · score 0.23
- lean body mass · score 0.23
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|
| AF-Q5JPI3-F1 | alphafold | PREDICTED | 75.93 | — |
Amino-acid sequence (329 residues)
MEMSGLSFSE MEGCRNLLGL LDNDEIMALC DTVTNRLVQP QDRQDAVHAI LAYSQSAEEL LRRRKVHREV IFKYLATQGI VIPPATEKHN LIQHAKDYWQ KQPQLKLKET PEPVTKTEDI HLFQQQVKED KKAEKVDFRR LGEEFCHWFF GLLNSQNPFL GPPQDEWGPQ HFWHDVKLRF YYNTSEQNVM DYHGAEIVSL RLLSLVKEEF LFLSPNLDSH GLKCASSPHG LVMVGVAGTV HRGNTCLGIF EQIFGLIRCP FVENTWKIKF INLKIMGESS LAPGTLPKPS VKFEQSDLEA FYNVITVCGT NEVRHNVKQA SDSGTGDQV
Explore Uncharacterized protein C3orf38 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets